Bulletin of the Korean Chemical Society

  • 제33권7호
  • /
  • Pages.2365-2368
  • /
  • 2012
  • /
  • 0253-2964(pISSN)
  • /
  • 1229-5949(eISSN)
대한화학회 (Korean Chemical Society)
권호 표지
DOI QR코드

DOI QR Code

Discovery of Novel 11β-HSD1 Inhibitors by Pharmacophore-Based Virtual Screening

  • 투고 : 2012.03.21
  • 심사 : 2012.04.23
  • 발행 : 2012.07.20
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

The $11{\beta}$-hydroxysteroid dehydrogenase type 1 ($11{\beta}$-HSD1) enzyme is involved in modulation of glucocorticoid activity within target tissues. This enzyme may contribute to obesity and/or metabolic disease through its action in adipose or liver tissue. Inhibition of $11{\beta}$-HSD1 has major therapeutic potential for glucocorticoid-associated diseases, including obesity, diabetes (wound healing), and muscle atrophy. To develop such therapeutics, we performed a pharmacophore-based virtual screening (VS) for identification of novel $11{\beta}$-HSD1 inhibitors and found that the VS hit compounds show potent inhibition of $11{\beta}$-HSD1 enzyme activity. Further, we present a binding model for active compounds. The proposed pharmacophore may serve as a useful guideline for future design of new chemical entities as $11{\beta}$-HSD1-targeted antidiabetic agents.

키워드

참고문헌

  1. Arnaldi, G.; Angeli, A.; Atkinson, A. B.; Bertagna, X.; Cavagnini, F.; Chrousos, G. P.; Fava, G. A.; Findling, J. W.; Gaillard, R. C.; Grossman, A. B.; Kola, B.; Lacroix, A.; Mancini, T.; Mantero, F.; Newell-Price, J.; Nieman, L. K.; Sonino, N.; Vance, M. L.; Giustina, A.; Boscaro, M. J. Clin. Endocrinol. Metab. 2003, 88, 5593-5602. https://doi.org/10.1210/jc.2003-030871
  2. Grundy, S. M.; Brewer, H. B., Jr.; Cleeman, J. I.; Smith, S. C., Jr.; Lenfant, C. Circulation 2004, 109, 433-438. https://doi.org/10.1161/01.CIR.0000111245.75752.C6
  3. Inagaki, K.; Otsuka, F.; Miyoshi, T.; Watanabe, N.; Suzuki, J.; Ogura, T.; Makino, H. Endocr. J. 2004, 51, 201-206. https://doi.org/10.1507/endocrj.51.201
  4. Kotelevitsev, Y.; Holmes, M. C.; Burchell, A.; Houston, P. M.; Schmoll, D.; Jamieson, P.; Best, R.; Brown, R.; Edwards, C. R. W.; Seckl, J. R.; Mullins, J. J. Proc. Natl. Acad. Sci. U.S.A. 1997, 94, 14924-14929. https://doi.org/10.1073/pnas.94.26.14924
  5. Masuzaki, H.; Paterson, J.; Shinyama, H.; Morton, N. M.; Mullins, J. J.; Seckl, J. R.; Flier, J. S. Science 2001, 294, 2166- 2170. https://doi.org/10.1126/science.1066285
  6. Kershaw, E. E.; Morton, N. M.; Dhillon, H.; Ramage, L.; Seckl, J. R.; Flier, J. S. Diabetes 2005, 54, 1023-1031. https://doi.org/10.2337/diabetes.54.4.1023
  7. Barf, T.; Williams, M. Drugs Future 2006, 31, 231-243. https://doi.org/10.1358/dof.2006.031.03.884977
  8. Zimmet, P.; Alberti, K. G.; Shaw, J. Nature 2001, 414, 782-787. https://doi.org/10.1038/414782a
  9. Joseph-McCarthy, D.; Alvarez, J. C. Proteins 2003, 51, 189-202. https://doi.org/10.1002/prot.10296
  10. Barreca, M. L.; De Luca, L.; Iraci, N.; Rao, A.; Ferro, S.; Maga, G.; Chimirri, A. J. Chem. Inf. Model. 2007, 47, 557-562. https://doi.org/10.1021/ci600320q
  11. Schuster, D.; Maurer, E. M.; Laggner, C.; Nashev, L. G.; Wilckens, T.; Langer, T.; Odermatt, A. J. Med. Chem. 2006, 49, 3454-3466. https://doi.org/10.1021/jm0600794
  12. Yang, H.; Dou, W.; Lou, J.; Leng, Y.; Shen, J. Bioorg. Med. Chem. Lett. 2008, 18, 1340-1345. https://doi.org/10.1016/j.bmcl.2008.01.020
  13. Patel, J. R.; Shuai, Q.; Dinges, J.; Winn, M.; Pliushchev, M.; Fung, S.; Monzon, K.; Chiou, W.; Wang, J.; Pan, L.; Wagaw, S.; Engstrom, K.; Kerdesky, F. A.; Longenecker, K.; Judge, R.; Qin, W.; Imade, H. D.; Stolarik, D.; Beno, D. W.; Brune, M.; Chovan, L. E.; Sham, H. L.; Jacobson, P.; Link, J. T. Bioorg. Med. Chem. Lett. 2007, 17, 750-755. https://doi.org/10.1016/j.bmcl.2006.10.074
  14. Catalyst, 2006, Version 4.9, Accelrys, Inc., San Diego, CA.
  15. Zheng, S.; Luo, X.; Chen, G.; Zhu, W.; Shen, J.; Chen, K.; Jiang, H. J. Chem. Inf. Model. 2005, 45, 856-862. https://doi.org/10.1021/ci050031j
  16. Mundt, S.; Solly, K.; Thieringer, R.; Hermanowski-Vosatka, A. Assay Drug Dev. Technol. 2005, 3, 367-375. https://doi.org/10.1089/adt.2005.3.367
  17. The PyMOL Molecular Graphics System, 2002, Version 0.99, DeLano Scientific, San Carlos, CA, U.S.A.
  18. Barf, T.; Vallgarda, J.; Emond, R.; Haggstrom, C.; Kurz, G.; Nygren, A.; Larwood, V.; Mosialou, E.; Axelsson, K.; Olsson, R.; Engblom, L.; Edling, N.; Ronquist-Nii, Y.; Ohman, B.; Alberts, P.; Abrahmsén, L. J. Med. Chem. 2002, 45, 3813-3815. https://doi.org/10.1021/jm025530f